ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Registered Nurse, Psychiatric/Mental Health, Adult

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,092Medicare Part D Prescriptions Filled, Including Refills
$1.4M Total Retail Price of All Prescriptions
348 Patients Receiving at Least One Drug in Part D
9%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
TRAZODONE HCL 760 59
BENZTROPINE MESYLATE 703 20 R
GABAPENTIN 566 57
ABILIFY 508 26
TOPIRAMATE 436 0
HALOPERIDOL 436 0
CITALOPRAM HBR 409 33
SERTRALINE HCL 372 55
ESCITALOPRAM OXALATE 332 22
OLANZAPINE 315 0
RISPERIDONE 270 13
QUETIAPINE FUMARATE 237 34
DIVALPROEX SODIUM ER 231 16
DIVALPROEX SODIUM 229 12
CYMBALTA 227 28
BUSPIRONE HCL 225 31
VENLAFAXINE HCL ER 222 0
SEROQUEL XR 192 0
CLOZAPINE 188 0
LITHIUM CARBONATE 178 22
PAROXETINE HCL 177 12
MIRTAZAPINE 144 20
LATUDA 135 0
INVEGA 133 0
RISPERDAL CONSTA 132 25
FLUOXETINE HCL 125 0
ZIPRASIDONE HCL 120 11
INVEGA SUSTENNA 113 0
SEROQUEL 113 18
CARBAMAZEPINE 106 0
HYDROXYZINE PAMOATE 103 0 R
OXCARBAZEPINE 98 0
LAMOTRIGINE 95 0
ZYPREXA 79 0
THIORIDAZINE HCL 76 13 R
CHLORPROMAZINE HCL 74 0
CLOMIPRAMINE HCL 74 0 R
PRAZOSIN HCL 70 0
PROPRANOLOL HCL 69 0
ZOLPIDEM TARTRATE 63 0
GEODON 60 0
AMITRIPTYLINE HCL 57 17 R
BUPROPION HCL 55 0
LEXAPRO 54 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.